Navigation Links
Ogden™ Soft Tissue Anchor System, Non-Sterile

ProductsOgden™ Soft Tissue Anchor System, Non-Sterile
Company USS Sports Medicine
Item Ogden™ Soft Tissue Anchor System, Non-Sterile
Features 
  • Cancellous threaded design
  • Self-Tapping
  • Description The USS Sports Medicine™ Ogden™ Non-Sterile Anchor is a nonabsorbable repair device to attach soft tissue to bone using sutures. The device is implanted into a prepared hole in the bone and is used to reattach damaged soft tissue. The anchors are manufactured from Titanium (6A14V ELI) alloy which conforms to ASTM (F136-92). The anchors are coated with Titanium Nitride (TiN) which conforms to (SAE AMS 2444). SUTURES Ogden Non-Sterile Anchors are indicated for use with multiple USP suture sizes. Selection of suture size should be based upon Anchor size, intended use and tensile strength requirements.
    Info USS Sports Medicine
    Customer Service: (800) 423-8772
    Web site: http://www.tycohealthcare.com

    Related medicine products :

    1. Ogden™ Soft Tissue Anchor System, Sterile Packs
    2. Straight Tissue Forceps
    3. Bishop-Harmon Straight Tissue Forceps
    4. Bishop-Harmon Curved Tissue Forceps
    5. Straight Tissue Forceps - Non-Magnetic
    6. Programmable Tissue Stainer TST 40, 115V, 60Hz, 100VA
    7. Programmable Tissue Stainer TST 40, 230V, 50Hz, 100VA
    8. Tissue-Tek DRS 2000
    9. Micro Tissue Forceps
    10. Micro Tissue Forceps with round handle
    11. LICOX Brain Tissue Oxygen Monitoring System
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    Medicine Products:
    (Date:8/22/2014)... LA The LSU Health New Orleans School ... Nursing Traineeship grant to increase access to advanced ... and under-represented groups, as well as veterans. The ... Department of Health and Human Services awarded the ... as the grant,s project director., The Advanced Education ...
    (Date:8/22/2014)... NV (PRWEB) August 22, 2014 Natural ... Kevin Richardson to restore his own vision from legally blind ... Michaels, prompting an investigative review. , “There is a ... or contacts for everyday function, and most people just think ... to corrective eye surgery that can be pretty risky at ...
    (Date:8/22/2014)... oncogenic somatic mutation at amino acid 918 in the ... small cell lung cancer (SCLC) tumors and enforced expression ... intracellular signaling and cell growth. , SCLC is a ... all lung cancers and is strongly associated with tobacco ... extensively examined for genomic alterations and targeted therapies are ...
    (Date:8/22/2014)... Vegas, NV (PRWEB) August 22, 2014 ... by Dr. Sen and Dr. Samantha Pearson to help ... contacts, and avoid corrective vision surgery by instead improving ... Michaels, prompting an investigative review. , “There’s a ... of dollars in revenue each year—it’s because people just ...
    (Date:8/22/2014)... Prairie du Sac, Wisconsin (PRWEB) August 22, 2014 ... FasciaDerm® PFTape™ System for Plantar Fasciitis, an exciting new ... The product allows you to stay active while you ... per application. This is truly a new technology – ... patented and affordable. , FasciaDerm® PFTape™ System for ...
    Breaking Medicine News(10 mins):Health News:Natural Clear Vision: Review Exposes Kevin Richardson’s Program for Restoring Vision Naturally 2Health News:Novel oncogenic RET mutation found in small cell lung cancer 2Health News:Restore My Vision Today: Review Exposes Natural Eye Restoration Guide by Dr. Sen and Dr. Samantha Pearson 2Health News:Mueller Introduces FasciaDerm® PFTape™ System for Plantar Fasciitis 2
    ... 28 WellSpring Pharmaceutical,Corporation, a growing North American-based ... named Chief Operating Officer.,Formerly, Ms. Shusko held the ... in early 2000. In her new role as ... her areas of oversight,to operations with an initial ...
    ... NQF-endorsed measures can improve quality of care for ... the,importance of quality healthcare for mothers and newborns ... measure and thereby,improve care received by mothers and ... discharge. Consensus standards improve quality,of care by standardizing ...
    ... who received blood that was 29 days or older faced ... Hospital patients who receive a transfusion of stored blood that ... developing one or more serious infections compared to those who ... pointed out that current U.S. regulations set the upper limit ...
    ... Device Designed to Minimize Discomfort and Pain Following ... a world-leading,manufacturer of ostomy and wound care products, ... a new post-operative ostomy,device. The product offers clinicians ... manage abdominal pain in the days and weeks ...
    ... Today, PARI Respiratory,Equipment presented a comparative study ... in-vitro performance and delivery,efficiency of budesonide inhalation ... study show that the LC Sprint,Reusable Nebulizer ... average,of 4.9 minutes, and had the highest ...
    ... of Portland,Oregon is pleased to announce its partnership ... a new company, Wellsource Health Solutions.,This joint venture ... provide,full-service solutions that meet the specific needs of ... Customers and their,participants will benefit from a new ...
    Cached Medicine News:Health News:WellSpring Pharmaceutical Corp. Names Wendy Shusko as New Chief Operating Officer 2Health News:National Quality Forum Endorses National Consensus Standards for Perinatal Care 2Health News:National Quality Forum Endorses National Consensus Standards for Perinatal Care 3Health News:Older Blood Boosts Chances of Infection in Transfusion Patients 2Health News:Older Blood Boosts Chances of Infection in Transfusion Patients 3Health News:ConvaTec Launches SUR-FIT Natura(R) Low-Pressure Adaptor 2Health News:ConvaTec Launches SUR-FIT Natura(R) Low-Pressure Adaptor 3Health News:PARI Respiratory Releases Results of Study Comparing Nebulizers Delivering Budesonide at CHEST 2008 2Health News:Wellsource Partners With Health Solutions Ltd. to Form Best-in-Class Health and Wellness Solutions for Its Clients. 2Health News:Wellsource Partners With Health Solutions Ltd. to Form Best-in-Class Health and Wellness Solutions for Its Clients. 3
    (Date:8/22/2014)... , Aug. 22, 2014 /PRNewswire/ - SQI ... that develops and commercializes proprietary technologies and products ... has entered into a Master Service Agreement to ... DNA-based pathogen detection assays. During the initial phase ... deliver an automated working prototype of one of ...
    (Date:8/21/2014)... , Aug. 21, 2014 Nektar ... International Inc. today announced positive results from its ... an investigational, extended half-life recombinant factor VIII (rFVIII) ... Factor (Recombinant)], which met its primary endpoint in ... arm compared to the on-demand arm. ...
    (Date:8/21/2014)... Canadian Epilepsy Alliance (CEA) is thrilled to announce the launch ... the most common neurological disorder in Canada ... tells a fictional story based on the experiences of 14-year-old ... "Despite the fact that epilepsy affects 1 ... lack of awareness out there," says Gail Dempsey , ...
    Breaking Medicine Technology:SQI Diagnostics Contracted to Automate Pathogen Detection Assays 2SQI Diagnostics Contracted to Automate Pathogen Detection Assays 3Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 2Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 3Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 5Action Heroes Harness Powers to Educate Children About Epilepsy 2Action Heroes Harness Powers to Educate Children About Epilepsy 3